Seven-day contraceptive patch: Agile began a Phase II trial in the U.S. and Australia of its 7-day transdermal combination contraceptive patch in 162 subjects

Agile Therapeutics Inc., West Conshohocken, Penn. Product: Seven-day contraceptive patch Business: Reproductive Therapeutic category: Hormone replacement Target: Estrogen and progesterone receptors D...